Oncogenic Mutations of PIK3CA in Human Cancers

Samuels, Yardena, Waldman, Todd·2010·Current Topics in Microbiology and Immunology
DOI 10.1007/82_2010_68

Cited by (292)

Items 201–292 of 292

  1. A Multiplex PCR-Based Next Generation Sequencing-Panel to Identify Mutations for Targeted Therapy in Breast Cancer Circulating Tumor Cells
    André Franken, Mahdi Rivandi, Liwen Yang, Bernadette Jäger, Natalia Krawczyk, Ellen Honisch, Dieter Niederacher, Tanja Natascha Fehm, Hans J. Neubauer · 2020 · Applied Sciences
  2. Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancer
    Marta Brunetti, Ioannis Panagopoulos, ILYÁ KOSTOLOMOV, Ben Davidson, Sverre Heim, Francesca Micci · 2020 · Oncology Letters
  3. In vitro analysis on inhibitory effect of sodium arsenite combined with astragaloside IV on HepG2 liver cancer cells
    Zhiwei Guo, Yajuan Xia, Guang Hao, Zhenzhen Gao, Ran Li, Ying Yang · 2021 · Alexandria Engineering Journal
  4. Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis
    Irem Congur, Ekin Koni, Onur Emre Onat, Zeynep Tokcaer Keskin · 2023 · PeerJ
  5. Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors
    Viola Bianca Serio, Maria Palmieri, Simona Innamorato, Lorenzo Loberti, Chiara Fallerini, Francesca Ariani, Enrica Antolini, Jasmine Covarelli, Massimo Maria Vaghi, Elisa Frullanti et al. · 2023 · Frontiers in Genetics
  6. High-Throughput Screening Strategies for Targeted Identification of Therapeutic Compounds in Colorectal Cancer
    Agnieszka B. Bialkowska, Vincent W. Yang · 2012 · Future Oncology
  7. Alpha lipoic acid modulates metabolic reprogramming in breast cancer stem cells enriched 3D spheroids by targeting phosphoinositide 3-kinase: In silico and in vitro insights
    Bandana Chakravarti, Manendra Singh Tomar, Faizan Abul Qais, Sana Raza, K.M. Abdullah, Gunjan Sharma, Archana Tewari, Abhishek Yadav, Pratima Gupta, Naibedya Chattopadhyay et al. · 2025 · Biomedicine & Pharmacotherapy
  8. Somatic gain-of-function mutations in BUD13 promote oncogenesis by disrupting Fbw7 function
    Jianfeng Chen, Xinyi Zhang, Xianming M. Tan, Pengda Liu · 2023 · The Journal of Experimental Medicine
  9. Intracranial venous malformation masquerading as a meningioma in PI3KCA‐related overgrowth spectrum disorder
    Aristotelis Filippidis, Hart G.W. Lidov, Alyaa Al‐Ibraheemi, Alfred Pokmeng See, Siddharth Srivastava, Darren B. Orbach, Katie L. Pricola · 2021 · American Journal of Medical Genetics Part A
  10. PI3K/mTOR inhibitor omipalisib prolongs cardiac repolarization along with a mild proarrhythmic outcome in the AV block dog model
    Joanne J.A. van Bavel, Caroline Pham, Henriëtte D.M. Beekman, Marien J. C. Houtman, Alexandre Bossu, Rolf W. Sparidans, Marcel A. G. van der Heyden, Marc A. Vos · 2022 · Frontiers in Cardiovascular Medicine
  11. Functional characterization of PI3K C2 domain mutations detected in breast cancer circulating tumor cells and metastatic cells
    Daniel J. Smit, Helena Brauer, Stefan Horn, Gökhan Yigit, Marie‐Therese Haider, Vivian Pogenberg, Udo Schumacher, Klaus Pantel, Manfred Jücker · 2024 · Cellular Signalling
  12. Combinatorial and fragment-based in silico design of PI3K-alpha natural hybrid antagonists for breast cancer therapeutics
    Navya Aggarwal, Shinjini Sen, Banashree Bondhopadhyay · 2025 · Exploration of Drug Science
  13. Assessing colorectal cancer heterogeneity: one step closer to tailored medicine
    Pavel Pitule, Miroslava Čedíková, Vladislav Třeška, Milena Králíčková, Václav Liška · 2013 · Journal of Applied Biomedicine
  14. Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients
    Zizhen Ming, Dongxian Jiang, Qin Hu, Xiaojing Li, Jie Huang, Yifan Xu, Yalan Liu, Chen Xu, Xiuguo Hua, Yingyong Hou · 2014 · Diagnostic Pathology
  15. Molecular portrait of stomach cancer associated with the Epstein–Barr virus
    E. Ignatova, Daria Seriak, Mikhail Yu. Fedyanin, Alexey Alexandrovich Tryakin, Илья Анатольевич Покатаев, S. F. Menshikova, Yu. V. Vakhabova, M. S. Karbyshev, Ksenia V. Smirnova, S. A. Tulyandin · 2020 · Advances in molecular oncology
  16. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors
    Vivek Gupta, Vishakha Vashisht, Ashutosh Vashisht, Ashis Kumar Mondal, Ahmet Alptekin, Harmanpreet Singh, Ravindra B Kolhe · 2024 · Genes
  17. Defining the Molecular Intricacies of Human Papillomavirus-Associated Tonsillar Carcinoma
    S. Sethi · 2025 · Cancer Control: Journal of the Moffitt Cancer Cente
  18. Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma
    Akshay Pratap, Andrea C. Qualman, Hedlund Garrett, Lindsey M. Westbrook, Erlinda The, Sanchayita Mitra, Mila Cordero, Kenneth Meza Monge, Juan Pablo Idrovo, Argudit Chauhan et al. · 2023 · Molecular & Cellular Oncology
  19. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis
    Sawako Ono, Katsutoshi Hirose, Shintaro Sukegawa, Kyoichi Obata, Masanori Masui, Kazuaki Hasegawa, Ai Fujimura, Katsumitsu Shimada, Satoko Nakamura, Akari Teramoto et al. · 2024 · Diagnostic Pathology
  20. Identification of genomic copy number variations associated with specific clinical features of head and neck cancer
    Boris Zagradišnik, Danijela Krgović, Špela Stangler Herodež, Andreja Zagorac, Bogdan Ćižmarević, Nadja Kokalj Vokač · 2018 · Molecular Cytogenetics
  21. Molecular Diagnosis in Ovarian Carcinoma
    Shailendra Dwivedi, Radhieka Misra, Purvi Purohit, Jeewan Ram Vishnoi, Puneet Pareek, Apul Goel, Sanjay Khattri, Praveen Sharma, Kamlesh Kumar Pant, Sanjeev Misra · 2019 · Springer eBooks
  22. The Importance of RTK Signaling Genes and their Inhibitors in Breast Cancer
    Maryam Rahimi, Setareh Talebi Kakroodi, Mansooreh Tajvidi · 2022 · Journal of Obstetrics Gynecology and Cancer Research
  23. Development of a novel PIK3CA-mutated pancreatic tumor mouse model and evaluation of the therapeutic effects of a PI3K inhibitor
    Yoshimasa Suzuki, Makoto Sugimori, Yushi Kanemaru, Sho Onodera, Hiromi Tsuchiya, Aya Ikeda, Ryosuke Ikeda, Yoshihiro Goda, Hiroaki Kaneko, Kuniyasu Irie et al. · 2025 · PLoS ONE
  24. The use of granulocyte colony-stimulating factors in the management of breast cancer patients
    Anna Bałata, E. Szombara, Zbigniew Ireneusz Nowecki, Katarzyna Pogoda · 2025 · Frontiers in Oncology
  25. PHEVIR: an artificial intelligence algorithm that predicts the molecular role of pathogens in complex human diseases
    Hongyi Zhou, Courtney Astore, Jeffrey Skolnick · 2022 · Scientific Reports
  26. A case of high‐risk neuroblastoma in a child with CLOVES syndrome
    Marina Girgis, Daniel J. Benedetti · 2023 · Pediatric Blood & Cancer
  27. Zirconium Hydride Catalysis Initiated by Tetrabutylammonium Fluoride
    Athenea N. Aloiau, Briana M. Bobek, Kelly E. Pearson, Kendall E. Cherry, Christopher R. Smith, John M. Ketcham, Matthew A. Marx, Stephen J. Harwood · 2024 · The Journal of Organic Chemistry
  28. Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications
    Mehrdad Hashemi, Asal Abolghasemi Fard, Bita Pakshad, Pezhman Shafiei Asheghabadi, Amineh Hosseinkhani, Atena Sadat Hosseini, Parham Moradi, Mohammadreza Mohammadbeygi Niye, Ghazal Najafi, Mohadeseh Farahzadi et al. · 2024 · Non-coding RNA Research
  29. Discovery of a selective PI3Kα inhibitor via structure-based virtual screening for targeted colorectal cancer therapy
    Hussam Albassam, Omar Almutairi, Majed Alnasser, Faisal Altowairqi, Faris Almutairi, Saad Ebrahim Alobid · 2025 · Journal of Enzyme Inhibition and Medicinal Chemistry
  30. Novel somatic mutations of PIK3CA in patients with colorectal cancer
    Chittibabu Vatte, Cyril Cyrus, Shahanas Chathoth, Ahmed A. Alsayyah, Nada Aldossary, Hassan M. Albisher, Rudaynah A. Alali, Mohammed Abdullah Alrubaish, Ali Al Amri · 2025 · World Academy of Sciences Journal
  31. Case Report: Activated PI3-kinase-δ syndrome and ovarian malignancies: a case series from the European ESID-APDS registry
    Maria Pia Esposto, Nizar Mahlaoui, Hassan Abolhassani, Koen van Aerde, Simone Cesaro, Anita Chandra, Stephan R. Ehl, Sven Kracker, Felipe Suárez, Vincent Barlogis et al. · 2025 · Frontiers in Immunology
  32. PIK3CA Mutations in Small Bowel Adenocarcinoma
    Santosh Shenoy · 2015 · Tumori Journal
  33. Case 1-2015
    Beverly Moy, Michelle Connolly Specht, Michael D. Lanuti, Elizabeth A. Rafferty, Melinda Fan Lerwill · 2015 · New England Journal of Medicine
  34. Molecular Pathogenesis of Colorectal Cancer
    Jan Král, Jana Slyšková, Pavel Vodička, Julius Špičák · 2016 · Klinicka onkologie
  35. Docking Study to Predict the Efficacy of Phosphatidylinositol 3-Kinase α Inhibitors
    Mahmoud A. Chawsheen, Hazem Abbas Al-Bustany · 2019 · ARO-The Scientific Journal of Koya University
  36. Prevalence of KRAS, PIK3CA, BRAF and AXIN2 gene mutations in colorectal cancer and its relationship with dental agenesis: a systematic review
    Francisco Javier Sir-Mendoza, Farith Damian González Martínez, Meisser Madera · 2021 · Revista de la Facultad de Medicina
  37. Prevalence and effect of PIK3CA H1047R somatic mutation among Indian head and neck cancer patients
    Arjita Ghosh, Anbalagan Moorthy · 2024 · Saudi Journal of Biological Sciences
  38. Transcriptomic Profile of Oral Cancer Lesions: A Proof-of-Concept Pilot Study of FFPE Tissue Sections
    Madison E. Richards, Micaela F. Beckman, Ernesto Martinez Duarte, Joel J. Napeñas, Michael Thomas Brennan, Farah Bahrani Mougeot, Jean-Luc Mougeot · 2025 · International Journal of Molecular Sciences
  39. Prevalence of targetable genomic alterations among a diverse population participating in the ASCO TAPUR Study
    Pam K. Mangat, M. Kelsey Kirkwood, Dominique C. Hinshaw, Elizabeth S. Garrett-Mayer, Richard L. Schilsky · 2025 · npj Precision Oncology
  40. GenBlosum: On Determining Whether Cancer Mutations Are Functional or Random
    Alejandro Leyva, Muhammad Khalid Khan Niazi · 2026 · Genes
  41. Aurora kinase B as a therapeutic target in HPV-induced cervical cancer: mechanisms and future perspectives
    Medha Karnik, Preethi G. Anantharaju, Arati Sharma, Olga Sukocheva, Edmund Tse, SubbaRao V. Madhunapantula · 2026 · Frontiers in Oncology
  42. Oncogenic PIK3CA enhances collective migration of mammary epithelial cells through ERK wave propagation
    Ali Dayoub, Artem I. Fokin, Sergey V. Leonov, Alexis M. Gautreau, Antonina Y. Alexandrova · 2026 · Journal of Cell Science
  43. Environmental Exposures, Tumor Heterogeneity, and Colorectal Cancer Outcomes
    Steven C. Agle, Prejesh Philips, Robert C.G. Martin · 2014 · Current Colorectal Cancer Reports
  44. Big Data Analytics and Molecular Medicine
    Kalyanasundaram Subramanian · 2016 · Springer eBooks
  45. PIK3CA Mutational Profiling in a Patient Cohort with HR+/HER2- Advanced Metastatic Breast Cancer at a Tertiary Cancer Center
    Osama A Alsmadi, Hikmat Abdel‐Razeq, Yazan Talab, Hazem Abdulelah, Zeena Shaheen, Abdelghani Tbakhi · 2024 · Fortune Journal of Health Sciences
  46. Effects of PIK3CA Gene Modifications on Radiosensitivity in Colorectal Cancer Cells
    Ghazi Alsbeih, Khaled Al-Hadyan · 2025 · Asian Pacific Journal of Cancer Prevention
  47. Integrating Context of Tumor Biology and Vaccine Design to Shape Multidimensional Immunotherapies
    Nathaniel S. Wang, Christian J. Maine · 2020 · Future Drug Discovery
  48. Epstein-Barr Virus-Associated Gastric Cancer: Old Entity with New Relevance
    Hugo Manuel Lopes de Sousa, Joana Ribeiro, Mafalda Timóteo · 2021 · Infectious diseases
  49. Screen-printed amperometric biosensors: A balancing act of manufacturing properties, cost efficiency and sensitivity
    Eva Melnik, Vanessa Thoeny, Steffen Kurzhals, Giorgio C. Mutinati, Malahat Asadi, Pooyan Mehrabi, Thomas G. M. Schalkhammer, Rainer Hainberger · 2022 · IEEE International Conference on Flexible and Printable Sensors and Systems (FLEPS)
  50. Interplay between Oncogenes and Tumor Suppressor Genes in Human Disease
    Sarah J. Parsons, John O. DaSilva, J. Thomas Parsons · 2015 · Elsevier eBooks
  51. Editorial
    Sujitra Detchokul, AG Frauman · 2014 · British Journal of Pharmacology
  52. Zirconium Hydride Catalysis Initiated by Tetrabutylammonium Fluoride
    Stephen J. Harwood, Athenea N. Aloiau, Briana M. Bobek, Kelly E. Pearson, Kendall E. Cherry, Christopher R. Smith, John M. Ketcham, Matthew A. Marx · 2024 · ChemRxiv
  53. Review Article Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer
    Snehal M. Gaikwad, Pritha Ray, Navi Mum · 2012
  54. Relación entre Polimorfismos de Nucleótido Simple (SNPs) en genes implicados en la proliferación celular, adhesión y mecanismos de supervivencia y la susceptibilidad al desarrollo del cáncer de mama
    Karina Beatriz Acosta · 2016
  55. Novel Options in Metastatic and Non-surgically Curable Bladder Cancer
    Yee Elise Vong Kiat, Jens Samol · 2018 · European Oncology & Haematology
  56. Cancer Stem Cells as Therapeutic Targets for Gastrointestinal Cancers
    Jyothi Priya Mandala, Srinivas Pittala, Gowru Srivani · 2020 · Springer eBooks
  57. Screening for PIK3CA mutations among Saudi women with ovarian cancer
    Wedad Saeed Al-Qahtani, Manal Abdullah Alduwish, Ebtesam M. Al-Olayan, Nada Hamad Aljarba, Al-Humaidhi Em, Fatimah Gh. Albani, Dalia Mostafa Domiaty, Aljohara M. Al‐Otaibi, Somaya M. Al Qattan, Alanood S. Almurshedi et al. · 2021 · Journal of Obstetrics and Gynaecology
  58. Genetic Analysis of Oligo-Metastatic Breast Cancer: Correlation with Clinicopathological Features
    Kuikui Jiang, Danyang Zhou, Fei Xu, Wen Xia, Qiufan Zheng, Qianyi Lu, Liye Wang, Kaping Lee, Hanjia Luo, Ping Zhang et al. · 2021 · Research Square
  59. Desarrollo de métodos integrados para la determinación de biomarcadores genéticos
    Sara Martorell · 2021
  60. Precision Medicine in Pancreatic Cancer
    Jaymes Beech · 2015
  61. Disorders of the Venous System
    Pascal Brouillard, Nisha Limaye, Laurence Myriam Boon, Miikka Vikkula · 2019 · Elsevier eBooks
  62. Phospholipid signaling: phosphoinositide kinases and phosphatases
    Takeshi Ijuin, Takehiko Sasaki · 2022 · Elsevier eBooks
  63. PIK3CA-mutated breast cancer: from research to clinical practice
    Anna L. Kornietskaya, Л. В. Болотина, Евдокимова Сэвиндж Физулиевна, V. V. Savchina, Yu. B. Karagodina, А. А. Качмазов · 2022 · Meditsinskiy sovet = Medical Council
  64. Peer Review #2 of "Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis (v0.1)"
    2023 · PeerJ
  65. Peer Review #1 of "Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis (v0.1)"
    2023 · PeerJ
  66. Peer Review #2 of "Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis (v0.2)"
    2023 · PeerJ
  67. Peer Review #1 of "Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis (v0.2)"
    2023 · PeerJ
  68. Chromosome 3
    Saurav Panicker, Satish Ramalingam · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  69. Drug and device testing in a preclinical model sensitive to cardiac arrhythmias
    Joanne J.A. van Bavel · 2023
  70. Novel Regulatory Mechanisms Of Protein Kinase B On Apoptosis Susceptibility And Cancer Dedifferentiation
    Arnatchai Maiuthed, Pithi Chanvorachote, Regine Schneider-Stock, Jutta Eichler · 2018
  71. Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes
    Kuikui Jiang, Danyang Zhou, Fei Xu, Wen Xia, Qiufan Zheng, Qianyi Lu, Rongzhen Luo, Ruoxi Hong, Shusen Wang · 2023 · BMC Cancer
  72. Predictive and prognostic features of early and locally advanced PIK3CA-mutated luminal HER2-negative breast cancer
    А. I. Stukan, Т. Yu. Semiglazova, Светлана Игоревна Кутукова, Vladimir Alekseyevich Porkhanov, V. N. Bodnya, Евгений Наумович Имянитов, V. V. Antipova, Zarema K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko · 2023 · Tumors of female reproductive system
  73. Computational investigations into structure and function impact of novel mutations identified in targeted exons from ovarian cancer cell lines
    Rucha M. Wadapurkar, Aruna Sivaram, Renu Vyas · 2024 · Journal of Biomolecular Structure and Dynamics
  74. Oncogenic composite mutations can be predicted by co‐mutations and their chromosomal location
    Asli Küçükosmanoglu, Carolien L. van der Borden, Lisanne E. A. de Boer, R. Verhaak, D. Noske, T. Wurdinger, Teodora Radonic, Bart A. Westerman · 2024 · Molecular Oncology
  75. The Molecular Biology of Cancer Disparities
    Jennyfer M. Garcí­a-Cárdenas, Carla Morán-Erazo, Erik Chávez-Vélez, Martín Terán-Navas, Ana Aleaga, Isaac Armendáriz‐Castillo, Andrés López‐Cortés, David Pesántez, Alberto Indacochea, Santiago Xavier Guerrero · 2024 · Interdisciplinary cancer research
  76. Association Between Somatic PIK3CA Mutations and Ancestry in South Asia: Prognostic Insights From a Sri Lankan Breast Cancer Study
    Tharini Ruwinya Cabraal, Iranthi Kumarasinghe, Ranga Perera, Jayantha Balawardane, Sameera Viswakula, Nandika Perera, Gayani Harendra Galhena · 2024 · medRxiv
  77. Molecular, genetic, and therapeutic advancements in prostate cancer research: a comprehensive literature review
    S. N. Singh · 2024 · International Journal of Research in Medical Sciences
  78. Predictive biomarkers for targeted therapy in daily anatomic pathology for ovarian tumors
    Niti Sureka, Sufian Zaheer · 2025 · Surgical and Experimental Pathology
  79. Deciphering the anticancer potential of hecogenin: An integrated network pharmacology, molecular docking, and cancer genome atlas data analysis approach
    Atharva Lokhande, Satish K. Mandlik, Deepa S. Mandlik · 2025 · In Silico Research in Biomedicine
  80. Mammalian Neuraminidase-1 is a Critical Target of Thromboxane Induced T-Cell Immunosuppression
    William W. Harless, Yunfan Li, Myron R. Szewczuk · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Expression and Mutation Analyses of Candidate Cancer Genes In Situ
    Sara Kiflemariam · 2012 · Uppsala University Publications (Uppsala University)
  82. Loss of PIK3CA Allows In Vitro Growth but Not In Vivo Progression of KRAS Mutant Lung Adenocarcinoma in a Syngeneic Orthotopic Implantation Model
    Abigail Booth, Giuseppe Caso, Barbara Rosati, Ya-Ping Jiang, Wei-Xing zong, Richard Z. Lin, Harold Bien · 2026 · Cells
  83. Learning from genomic data : efficient representations and algorithms.
    Marine Le Morvan · 2018
  84. EVT-701 : targeting electron transport chain complex I as therapeutic approach in cancer
    Raquel Luna Yolba · 2021 · theses.fr (ABES)
  85. A PIK3CA and NF1 expression-based prognostic signature derived from Mendelian randomization identifies causal immune-regulatory determinants of glioblastoma outcomes
    Qinbiao Chen, Min Luo, Wenjing Lin, Linlin Lu, Cheng Zhong, Anmin Liu, Lin Xie · 2026 · Discover Oncology
  86. Extracellular vesicles as systems-level regulators of tumor progression: Integrating signaling networks, microenvironment reprogramming, and therapy resistance
    Deepthi Maria Mathew, Ankit Kumar Bharti S, Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan, Babu Gajendran, S. Nishu · 2026 · Pathology - Research and Practice
  87. Synovial Sarcoma in the Setting of Klippel–Trenaunay Syndrome: A Rare Case
    Venkatesh Naru, Ramya Priya Rallapeta, V Nithya, Silpa Kadiyala, Alekhya Maduri · 2026 · Indian Journal of Nuclear Medicine
  88. Understanding the distinct role of PI3K(p110α) in cancer and the heart to prevent chemotherapy-induced cardiotoxicity: mechanisms and therapeutic opportunities
    Teleah G. Belkin, Yow Keat Tham, Amanda J. Edgley, Julie R. McMullen · 2026 · Frontiers in Cardiovascular Medicine
  89. Co-Mutation Landscape of PIK3CA Across Multiple Adenocarcinomas: Insights from TCGA Data
    Perçin Pazarcı · 2026 · Scientific reports in medicine.
  90. Mapping Mutations and Signaling Network Interactions to Guide Precision Therapy in Gallbladder Cancer
    Nisha Manav, Akanksha Kashyap, Lakshay Malhotra, Rajegowda Chethan, Chandra Prakash Prasad · 2026 · Cancer Reports
  91. BindingDB Entry 50020790: Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein.
    BindingDB · 2024 · UC San Diego
  92. BindingDB Entry 50014266: Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers.
    BindingDB · 2022 · UC San Diego